“The Role of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in the Treatment of Heart Failure in Patients with Type 2 Diabetes Mellitus”, APMPLMI, vol. 3, no. 1, pp. 1–10, May 2022, doi: 10.52914/apmp.v3i1.42.